← Back to S&P 500 Top 20

Weekly Summary and Featured Stock Analysis

The AI Market Pulse - Week of 2026-06-28

Featured Stock: JPM - JPMorgan Chase & Co.

For the latest stock analysis and interactive charts:
📊 Open Stock Analysis ↗

📊 Weekly Investor Dashboard Ranking

Simple metrics for smarter decisions - which stocks are leading vs lagging?
Last Updated: June 29, 2026 12:02 AM ET

Ticker Price Weekly Change Trend
Price direction (EMA)
Risk
Based on price swings
From 52W High Past P&L News Sentiment
ABBV $253.35 +11.3% N/A Medium 0.0% +24.3% (+12.6%)
Entry: 2026-04-29 @ $203.89
Slightly Bullish
LLY $1208.12 +6.6% N/A High 0.0% N/A
Entry: 2026-06-26 @ $1208.12
Slightly Bullish
JNJ $254.66 +5.7% N/A Medium 0.0% N/A
Entry: 2026-06-26 @ $254.66
Slightly Bullish
V $336.23 +4.3% N/A Medium 0.0% +2.7% (+4.2%)
Entry: 2026-05-01 @ $327.35
Slightly Bullish
JPM $329.05 +2.6% N/A Medium 0.0% +5.3% (+2.6%)
Entry: 2026-06-05 @ $312.37
Slightly Bullish
BRK-B $498.66 +1.9% N/A Low 0.0% N/A
Exit: 2026-03-23 @ $479.98
Slightly Bullish
MA $499.02 +1.8% N/A Medium 0.0% +0.8% (+1.9%)
Entry: 2026-02-23 @ $495.18
Slightly Bullish
ORCL $148.53 +0.0% N/A High 0.0% N/A
Exit: 2026-06-11 @ $184.10
Neutral
BAC $57.88 +0.0% N/A Medium 0.0% N/A
Exit: 2026-05-13 @ $49.58
Slightly Bullish
PLTR $112.93 +0.0% N/A High 0.0% N/A
Exit: 2026-06-26 @ $112.93
Neutral
AMZN $232.69 -2.5% N/A High 0.0% N/A
Exit: 2026-06-22 @ $232.79
Slightly Bullish
AAPL $283.78 -2.5% N/A Medium 0.0% +15.2% (-3.0%)
Entry: 2026-01-20 @ $246.24
Slightly Bullish
META $550.25 -3.0% N/A High 0.0% N/A
Exit: 2026-05-05 @ $604.40
Slightly Bullish
WMT $115.69 -4.4% N/A Medium 0.0% N/A
Exit: 2026-05-28 @ $118.90
Slightly Bullish
AVGO $365.02 -4.5% N/A High 0.0% N/A
Exit: 2026-06-11 @ $384.96
Slightly Bullish
MSFT $372.97 -4.5% N/A High 0.0% N/A
Exit: 2026-06-12 @ $390.74
Slightly Bullish
NVDA $192.53 -6.2% N/A High 0.0% +42.5% (-9.3%)
Entry: 2025-05-14 @ $135.15
Neutral
GOOGL $337.39 -6.2% N/A High 0.0% +1.4% (-6.7%)
Entry: 2026-04-14 @ $332.71
Slightly Bullish
TSLA $379.71 -6.6% N/A High 0.0% N/A
Exit: 2026-06-11 @ $399.15
Slightly Bullish
XOM $136.54 -7.1% N/A Medium 0.0% +10.4% (-8.5%)
Entry: 2026-01-05 @ $123.69
Slightly Bullish
📈 Increasing Sentiment (17 stocks) - Click to expand
📈 MA (+3.7)
📰 MasterCard (MA) Increases Despite Market Slip: Here's What Y...📰 Forget Mastercard: 1 Dominant Payment Tollbooth to Buy Hand ...📰 Here is What to Know Beyond Why Mastercard Incorporated (MA)...
📈 JPM (+3.3)
📰 Expect DEI to be a non-factor in the horse race for Jamie Di...📰 What Will Q2 Earnings Season Show?...📰 A relationship banker and a risk manager: Meet the two candi...
📈 JNJ (+3.3)
📰 Ignore Every Utility Bill And Still Keep The Lights On. Here...📰 How Much Of Your Dividend Income Do You Actually Get To Keep...📰 Solvonis CEO on progress with potential alcohol use disorder...
📈 BAC (+3.3)
📰 Got $1,000 to Invest? This Stock Could Turn It Into $100,000...📰 JPMorgan Chase Pairs a 10% Dividend Hike With a New $50 Bill...📰 Big Banks Pass "Stress Test" & Earnings Expectations for Fin...
📈 BRK-B (+3.2)
📰 Berkshire May Just Save You From A Likely Market Crash...📰 Warren Buffett's Berkshire Hathaway Is Sitting on Nearly $40...📰 Berkshire CEO Greg Abel sworn in as U.S. citizen at baseball...
📈 GOOGL (+2.7)
📰 Google limits Meta's use of its Gemini AI models: report...📰 Alphabet Pulled Back Hard. Here Are My Top 3 Megacaps to Buy...📰 Anthropic Could Become the Most Valuable Software Company in...
📈 AAPL (+2.3)
📰 Apple Just Handed These 4 Memory Stocks Their Best News of t...📰 Apple's Price Hikes Aren't Just an AI Problem...📰 SpaceX Has Real Value—But These 3 Stocks Have Better Odds Ri...
📈 TSLA (+2.3)
📰 Tesla Reports Q2 Deliveries in a Matter of Days. Here's the ...📰 SpaceX Has Real Value—But These 3 Stocks Have Better Odds Ri...📰 Tesla Completes Key AI Chip Milestone in Its Push Beyond the...
📈 LLY (+2.2)
📰 Seniors in Medicare are about to get landmark obesity drug c...📰 Why Eli Lilly Gained 7% On Friday...📰 Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally...
📈 ABBV (+2.2)
📰 SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric ...📰 Lilly, J&J and AbbVie Hit New Highs...📰 AbbVie to Host Second-Quarter 2026 Earnings Conference Call...
📈 AMZN (+2.1)
📰 Forget Prime Day. Amazon's AI Empire Makes It the World's Mo...📰 Anthropic Could Become the Most Valuable Software Company in...📰 AI Demand Is Outstripping Supply — Even Google Can't Keep Up...
📈 WMT (+2.0)
📰 Weekend Morning Brew: Micron and Apple Lead Key Stock Moveme...📰 Prediction: Walmart Will Rejoin the $1 Trillion Club by 2027...📰 Walmart vs. Target: Which Stock Offers Better Long-Term Valu...
📈 AVGO (+1.9)
📰 3 Artificial Intelligence Stocks You Can Buy and Hold for th...📰 The Billionaire Who Sold Nvidia Too Early Just Bought 196,00...📰 Will Amazon, Taiwan Semiconductor, SpaceX, or Broadcom Be th...
📈 V (+1.8)
📰 Remitly Global vs. Visa: Which FinTech Stock Is a Better Buy...📰 Can Visa's New Travel Play Become Its Next Growth Driver?...📰 Forget Mastercard: 1 Dominant Payment Tollbooth to Buy Hand ...
📈 XOM (+1.8)
📰 My Top 10 High-Yield Picks For July 2026: One Yields More Th...📰 The Market Is Dead Wrong: I'm Buying Dirt-Cheap Energy Stock...📰 ExxonMobil vs. Enterprise Products: Which Energy Giant Has t...
📈 MSFT (+1.4)
📰 ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Microsof...📰 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Microsoft Investo...📰 This Artificial Intelligence (AI) Cloud Stock Has Crushed Am...
📈 META (+1.3)
📰 Google limits Meta's use of its Gemini AI models: report...📰 Meta Platforms vs. Snap: Comparing Revenue Scale and Recent ...📰 AI Demand Is Outstripping Supply — Even Google Can't Keep Up...
🔔 Volume Anomaly Alerts (This Week) - Click to expand

✅ No unusual volume detected this week.

🎯 JPM - Price Levels & Risk

Current
$329.05 +2.6%
Today's price · Weekly change
Support
$312.22
Price floor - buyers step in
Resistance
$330.86
Price ceiling - sellers step in
Stop Loss
$318.02
Exit consideration to limit losses
52W High
$329.05
0.0% from peak
52W Low
$329.05
+0.0% above bottom
Risk Level
Medium
Based on price swings
Volatility
2.3%/day
Avg daily price change
Trend
N/A
Price direction (EMA)
From High
0.0%
Distance from 52W peak
Past P&L
+5.3%
Entry: 2026-06-05 @ $312.37
Past Win Rate
64%
Backtest success rate

🔬 JPM - Deep Technical Scan

RSI (14)
60.3
Neutral
MACD Histogram
1.369
Bullish
ADX
28.5
Strong trend
BB Position
71%
Mid-range
Confluence
3B / 0S
WEAK
Signal
HOLD
Bullish
ML Probability
47% next day up
5d 40% | 20d 50%
Backtest Win Rate
59%
10W / 7L (17 trades)
Avg Trade P&L
+7.6%
Best: +58.3% / Worst: -11.0%

🤖 JPM - AI Deep Analysis

Powered by Gemini 2.0 Flash · AI Sentiment grounded with Google Search

🎯 Price Targets

THE ANALYST CONSENSUS:
Average Target: $343.48 (+4.4% Upside)
High Target: $391.00

🔮 SCENARIOS (30-60 Days)


🟢 Bull: $343.48 (+4.4%) — Sustained strong financial performance and a positive economic outlook, supported by a healthy medium-term trend, could drive JPM to its average analyst target.
🟡 Base: $321.54 (-2.3%) — Minor market volatility or profit-taking could lead to a slight consolidation, while the stock remains above its key medium-term support.
🔴 Bear: $318.02 (-3.4%) — A significant market correction or unexpected negative news could challenge the current trend and push the stock to its stop-loss level.

RISK/REWARD:
Upside to Bull: +4.4%
Downside to Bear: -3.4%
Verdict: Favorable

⚠️ Risk Assessment

THREAT ASSESSMENT: JPM

1. THREAT LEVEL: ELEVATED
* Why: The price is directly at a critical resistance level, risking immediate rejection despite strong underlying bullish momentum.

2. THE #1 KILLER:
* Risk: Failure to decisively break and hold above the immediate resistance at $330.86.
* Consequence: A sharp reversal from resistance, triggering the stop loss and potentially leading to a deeper correction towards structural support.

3. RISK FACTOR BREAKDOWN:
* Technicals: The short-term trend is bullish, reinforced by a healthy medium-term trend where the price is above its 5-month trend line, which is also rising. ADX at 28.5 indicates a trending environment, but not yet an explosive breakout, while RSI at 60.3 suggests strong buying pressure without being overextended.
* Levels: The immediate resistance at $330.86 is a significant hurdle. A failure to clear this level could quickly send the price back towards the stop loss at $318.02, and potentially down to the more substantial support at $312.22.
* Psychology: The strong bullish confluence (3 Bullish / 0 Bearish) indicates high market confidence, which can lead to aggressive buying into resistance. However, this also sets the stage for a more pronounced sell-off if the resistance holds and bullish expectations are not met.

4. WORST CASE SCENARIO:
The price attempts to breach $330.86, fails to gain traction, reverses sharply, triggers the stop loss at $318.02 for a -3.4% loss, and continues its decline towards the $312.22 support level.

📰 AI Sentiment Google Search Grounded

No recent news found within the last 48 hours for JPMorgan Chase & Co. (JPM). The most recent relevant news found dates back to June 26, 2026.

⚖️ Peer Benchmarking — JPM vs FITB, HTB

Powered by Gemini 2.0 Flash · Two-Brain Architecture (Analyst + News Hunter)

MetricJPMFITBHTB
Price$329.05$56.31$49.04
TrendUptrendUptrendUptrend
RSI60.370.368.1
ADX28.527.826.1
P/E15.819.012.7
Fwd P/E14.011.413.1
Rev Growth+12.7%+33.0%+9.3%
EPS Growth+17.2%-78.9%+17.9%
Debt/Equity0.000.000.00
Beta1.000.950.81
Win Rate59%63%47%
SentimentSlightly BullishSlightly BearishBullish

⚖️ AI Head-to-Head Comparison

# TOP RANKED: JPM
> Reason: JPMorgan Chase & Co. demonstrates superior macro trend confirmation, balanced growth, and lower risk, making it the most robust investment among the three.

---

HEAD-TO-HEAD BREAKDOWN



1. TREND


JPM exhibits a strong bullish trend with an ADX of 28.5, a neutral RSI of 60.3, and a bullish MACD. Crucially, its price is above its 5-month trend line, which is also rising, indicating a fundamentally confirmed and healthy medium-term trend. FITB and HTB also show bullish trends with ADX values of 27.8 and 26.1 respectively, and bullish MACD signals. However, FITB's RSI is overbought at 70.3, and both FITB and HTB lack confirmed macro support data regarding their 5-month trend lines. JPM's clear macro trend confirmation gives it an edge.
Leader: JPM 📈

2. GROWTH


JPM presents a balanced growth profile with 12.7% revenue growth and 17.2% EPS growth, coupled with the highest analyst target upside of +4.4%. FITB boasts the highest revenue growth at 33.0% but is significantly hampered by a -78.9% EPS growth year-over-year, and a lower analyst target of +3.3%. HTB shows 9.3% revenue growth and 17.9% EPS growth, but the lowest analyst target upside at +2.1%. JPM's consistent positive growth across both revenue and EPS, combined with a higher analyst target, makes it the leader.
Leader: JPM 🚀

3. VALUE


HTB stands out with the most attractive valuation metrics, featuring the lowest P/E ratio at 12.7 and the lowest PEG ratio at 1.41. JPM follows with a P/E of 15.8 and a PEG of 1.75. FITB has the highest current P/E at 19.0 and PEG at 2.05, despite having the lowest forward P/E at 11.4. Based on current P/E and PEG, HTB offers the best value.
Leader: HTB 💰

4. SAFETY


JPM offers the lowest stop loss risk at -3.4% and a solid backtest win rate of 59% with an average P&L of +7.6%. HTB has the lowest beta at 0.81, indicating less volatility, but a higher stop loss risk of -7.0% and the lowest backtest win rate at 47%. FITB has a slightly lower beta than JPM at 0.95 and the highest backtest win rate at 63%, but also a higher stop loss risk of -7.0%. JPM's significantly lower stop loss risk and strong average P&L make it the safer choice for capital preservation.
Leader: JPM ✅

5. FLAGS


JPM currently trades at its 52-week high, but its RSI is neutral, indicating no immediate overbought concerns. FITB shows significant red flags: its RSI is overbought at 70.3, and its EPS growth is a concerning -78.9% year-over-year. HTB also trades at its 52-week high and has a relatively low backtest win rate of 47%. JPM has the fewest immediate warning signs.

---

BOTTOM LINE


JPMorgan Chase & Co. (JPM) is the top pick due to its confirmed bullish macro trend, balanced and positive growth metrics, and superior risk management with a tighter stop loss, making it a more reliable investment in the current environment.

📰 AI Sentiment Comparison Google Search Grounded

SENTIMENT COMPARISON:

JPM: MIXED — Positive news regarding stress test results, a dividend increase, and a share buyback is balanced by leadership transition headlines and succession uncertainty.
FITB: BULLISH — Strong analyst ratings, outperformance against indices, positive outlook due to the Comerica acquisition, and passing stress tests.
HTB: No recent news found in the last 48 hours directly related to the company's financial performance or stock.

NEWS EDGE: FITB has the strongest near-term catalyst due to multiple bullish analyst upgrades and price target increases, coupled with strong performance driven by the Comerica acquisition and positive stress test results, all ahead of its Q2 earnings report.

CATALYST TIMELINE:
JPM: Q2 2026 Earnings on Tuesday, July 14, 2026, before market open.
FITB: Q2 2026 Earnings on Friday, July 17, 2026.
HTB: Next earnings release expected on July 28, 2026.

Fundamental Health Check - JPM

Don't just follow the hype. Here's what the fundamentals tell us.

Moat Score
8/10
Financial Fitness
6/10
ROE
16.5%
Debt/Equity
0.00

Why Fundamentals Matter More Than News Today

While JPM has positive sentiment (+3.3), its fundamentals tell a consistent story.

With a Moat Score of 8/10 and ROE of 16.5%, the company demonstrates strong competitive advantages.

Key Metrics: Gross Margin N/A | Revenue Growth +12.7% | Institutional Ownership 76%

Featured Stock: Bull vs. Bear AI Summary - JPM

AI-generated analysis removing human bias from the investment thesis

Bull Case

  • Strong earnings growth of 17.2% demonstrates robust profitability expansion
  • Revenue growing at 12.7% indicates healthy demand
  • ROE of 16.5% shows efficient capital utilization
  • Positive news sentiment (+3.3) suggests favorable market perception
  • 76% institutional ownership signals professional investor confidence
  • Strong analyst consensus with 14 Buy vs 0 Sell ratings

Bear Case

  • Limited bearish risks identified in current data

Sentiment vs. Noise Filter - JPM

Distinguishing between market noise and actionable signals

Total Articles Analyzed
31
Bullish Articles
17
Bearish Articles
1
Neutral Articles
13

Signal Quality Assessment

Our sentiment engine analyzed 31 mentions of JPM this week, filtering for institutional-grade news sources.

Result: Slightly Bullish overall sentiment with a score of +3.3.

Moderate noise detected - sentiment readings may be less reliable

📰 View News Sources (Top 11 of 31 analyzed)

🟢 Bullish (17)

🔴 Bearish (1)

⚪ Neutral (13)

What the AI Missed

Transparency builds trust. Here are the known limitations this week.

DISCLAIMER: This report is for informational and educational purposes only and does not constitute investment advice. Ultra Stock Analysis Pro is not a registered investment advisor; information is impersonal and not tailored to individual circumstances. AI-generated content may contain errors — verify before acting. Past performance is not indicative of future results. Technical analysis based on historical data through June 27, 2026. Please conduct your own due diligence before making investment decisions. Inherent in any investment is the potential for loss. No information provided on this platform constitutes a recommendation to buy, sell, or hold any security, or a solicitation of an offer to buy or sell any security.